ArticleResearch square2025
Macronutrient and Bioactive Profiles of Donor Milk Differ in Commercial vs Non-Profit Milk Banks.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
9 authors.
Funding
Abstract
Objective: The objective was to explore variation of macronutrient and bioactive content between levels of human milk-derived human milk fortifier (HM-HMF), and between donor human milk (DHM) from commercial vs non-profit banks. Study Design: We analyzed the concentration of macronutrients, Immunoglobulin A (IgA), and cortisol in multiple lots of each HM-HMF product (20, 24, 26, 28, and 30 kcal/oz) using multiple methods. Result: At each level of caloric density (p<0.0001), protein, carbohydrate, and caloric concentration in HM-HMF increased with minor exceptions while fat and cortisol concentrations did not differ. Total IgA concentrations differed by product type (p <0.0001). Protein concentration did not differ between commercial and non-profit donor milk banks while carbohydrates, fat, calories, and cortisol were higher, and IgA was lower. Lot-to-lot variability of all DHM components was lower in commercial DHM. Conclusion: This study expands data on the variability in the composition of DHM originating from various sources.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.